Ungerer M - Search Results

1

Cyclopeptide COR-1 to treat beta1-adrenergic receptor antibody-induced heart failure.

Boivin-Jahns V, Uhland K, Holthoff HP, Beyersdorf N, Kocoski V, Kerkau T, Münch G, Lohse MJ, Ungerer M, Jahns R. Boivin-Jahns V, et al. Among authors: ungerer m. PLoS One. 2018 Aug 20;13(8):e0201160. doi: 10.1371/journal.pone.0201160. eCollection 2018. PLoS One. 2018. PMID: 30125285 Free PMC article.

2

Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-β1-adrenergic receptor antibody neutralization and of immune parameters.

Münch G, Boivin-Jahns V, Holthoff HP, Adler K, Lappo M, Truöl S, Degen H, Steiger N, Lohse MJ, Jahns R, Ungerer M. Münch G, et al. Among authors: ungerer m. Eur J Heart Fail. 2012 Nov;14(11):1230-9. doi: 10.1093/eurjhf/hfs118. Epub 2012 Sep 11. Eur J Heart Fail. 2012. PMID: 22968742 Free article. Clinical Trial.

3

Detection of anti-β1-AR autoantibodies in heart failure by a cell-based competition ELISA.

Holthoff HP, Zeibig S, Jahns-Boivin V, Bauer J, Lohse MJ, Kääb S, Clauss S, Jahns R, Schlipp A, Münch G, Ungerer M. Holthoff HP, et al. Among authors: ungerer m. Circ Res. 2012 Aug 31;111(6):675-84. doi: 10.1161/CIRCRESAHA.112.272682. Epub 2012 Jul 18. Circ Res. 2012. PMID: 22811559

4

The GPVI-Fc fusion protein Revacept reduces thrombus formation and improves vascular dysfunction in atherosclerosis without any impact on bleeding times.

Ungerer M, Li Z, Baumgartner C, Goebel S, Vogelmann J, Holthoff HP, Gawaz M, Münch G. Ungerer M, et al. PLoS One. 2013 Aug 12;8(8):e71193. doi: 10.1371/journal.pone.0071193. eCollection 2013. PLoS One. 2013. PMID: 23951109 Free PMC article.

5

Prolonged TSH receptor A subunit immunization of female mice leads to a long-term model of Graves' disease, tachycardia, and cardiac hypertrophy.

Holthoff HP, Goebel S, Li Z, Faßbender J, Reimann A, Zeibig S, Lohse MJ, Münch G, Ungerer M. Holthoff HP, et al. Among authors: ungerer m. Endocrinology. 2015 Apr;156(4):1577-89. doi: 10.1210/en.2014-1813. Epub 2015 Jan 6. Endocrinology. 2015. PMID: 25562617

6

Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.

Ungerer M, Faßbender J, Li Z, Münch G, Holthoff HP. Ungerer M, et al. Clin Rev Allergy Immunol. 2017 Apr;52(2):182-193. doi: 10.1007/s12016-016-8562-7. Clin Rev Allergy Immunol. 2017. PMID: 27368808 Free PMC article. Review.

7

Cyclic Peptides for Effective Treatment in a Long-Term Model of Graves Disease and Orbitopathy in Female Mice.

Holthoff HP, Li Z, Faßbender J, Reimann A, Adler K, Münch G, Ungerer M. Holthoff HP, et al. Among authors: ungerer m. Endocrinology. 2017 Jul 1;158(7):2376-2390. doi: 10.1210/en.2016-1845. Endocrinology. 2017. PMID: 28368444

8

Antigen-specific therapy of Graves´ disease and orbitopathy by induction of tolerance.

Ungerer M, Fabbender J, Holthoff HP. Ungerer M, et al. Front Biosci (Landmark Ed). 2018 Jun 1;23(11):2044-2052. doi: 10.2741/4688. Front Biosci (Landmark Ed). 2018. PMID: 29772544 Free article.

9

Therapeutic Effects of Short Cyclic and Combined Epitope Peptides in a Long-Term Model of Graves' Disease and Orbitopathy.

Faßbender J, Holthoff HP, Li Z, Ungerer M. Faßbender J, et al. Among authors: ungerer m. Thyroid. 2019 Feb;29(2):258-267. doi: 10.1089/thy.2018.0326. Thyroid. 2019. PMID: 30618332

10

Thyroid-stimulating hormone receptor (TSHR) fusion proteins in Graves' disease.

Holthoff HP, Uhland K, Kovacs GL, Reimann A, Adler K, Wenhart C, Ungerer M. Holthoff HP, et al. Among authors: ungerer m. J Endocrinol. 2020 Aug 1;246(2):135-147. doi: 10.1530/JOE-20-0061. J Endocrinol. 2020. PMID: 32573180

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters